ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 335787 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 335787; 2) Community: the network communities that were significantly associated with the response to NSC 335787; 3) Molecule: the relationships between components within communities and NSC 335787; 4) MDR: the compounds that were significantly associated with the NSC 335787.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.00396536695012845 0.44041708
NSC 750970 3-[(E)-1-(3-1-[(4-fluorophenyl)sulfonyl]-4-piperidylimidazo[1,5-a]pyridin-1-yl)methylidene]-2-indolinone 0.00396536695012845 -0.32030461
NSC 681644 Camptothecin Derivative 0.00396536695012846 -0.09804472
NSC 683557 Camptothecin Derivative 0.00396536695012846 0.03993889
NSC 697685 Null 0.00396536695012846 0.067953395
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.00526022686151165 0.57246162
NSC 658441 2-Amino-5,8-dihydroxy-1,4-naphthoquinone 0.00526022686151165 0.5389898
NSC 682995 5,8-Quinolinedione, 2-methyl- 0.00526022686151165 0.44636357
NSC 683326 Null 0.00526022686151165 0.47360694
NSC 715572 Null 0.00526022686151165 0.43029738
Total:109  Current:21    [First] [Prev] [Next] [Last]